Human disease
plasma cell myeloma
Mondo defines it as: “A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia. Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)”
1 disease group in OMIA reaches this disease, through OMIA's own Mondo link or its OMIM numbers. The page shows the chain. It does not say whether an animal is a model of this disease.
Animal diseases
By natural-model score for this disease, highest first. The score says how complete and how well supported each chain is, by stated rules. How the score works.
| OMIA group | Name | Found by | Species | The chain reached | Score |
|---|---|---|---|---|---|
| 37 | Amyloidosis, generic | OMIA's OMIM numbers | 29 | Human disease |
40.0
|
Human genes
Each human gene of these disease groups that Open Targets links to this disease.
Open Targets links none of these groups' human genes to this disease.
Drugs tested for this disease
Each ChEMBL drug that has been tested for this disease, and the human genes above it acts on, if any. Open Targets gives some drugs, such as most enzyme replacement therapies, no target gene.
| Drug | Acts on | Latest stage for this disease |
|---|---|---|
| Belantamab Mafodotin | None of these genes | Approved |
| Bortezomib | None of these genes | Approved |
| Carfilzomib | None of these genes | Approved |
| Carmustine | None of these genes | Approved |
| Ciltacabtagene Autoleucel | None of these genes | Approved |
| Cyclophosphamide Anhydrous | None of these genes | Approved |
| Daratumumab | None of these genes | Approved |
| Denosumab | None of these genes | Approved |
| Dexamethasone | None of these genes | Approved |
| Doxorubicin | None of these genes | Approved |
| Elotuzumab | None of these genes | Approved |
| Elranatamab | None of these genes | Approved |
| Hyaluronidase (Human Recombinant) | None of these genes | Approved |
| Idecabtagene Vicleucel | None of these genes | Approved |
| Interferon Alfa-2b | None of these genes | Approved |
| Isatuximab | None of these genes | Approved |
| Ixazomib | None of these genes | Approved |
| Ixazomib Citrate | None of these genes | Approved |
| Lenalidomide | None of these genes | Approved |
| Linvoseltamab | None of these genes | Approved |
| Melphalan | None of these genes | Approved |
| Melphalan Flufenamide | None of these genes | Approved |
| Motixafortide | None of these genes | Approved |
| Motixafortide Acetate | None of these genes | Approved |
| Panobinostat | None of these genes | Approved |
| Plerixafor | None of these genes | Approved |
| Pomalidomide | None of these genes | Approved |
| Selinexor | None of these genes | Approved |
| Sirolimus | None of these genes | Approved |
| Talquetamab | None of these genes | Approved |
| Teclistamab | None of these genes | Approved |
| Thalidomide | None of these genes | Approved |
| Vincristine | None of these genes | Approved |
| Zoledronic Acid Anhydrous | None of these genes | Approved |
| Alnuctamab | None of these genes | Phase 3 |
| Amifostine | None of these genes | Phase 3 |
| Anitocabtagene Autoleucel | None of these genes | Phase 3 |
| Arlocabtagene Autoleucel | None of these genes | Phase 3 |
| Armodafinil | None of these genes | Phase 3 |
| Bendamustine | None of these genes | Phase 3 |
| Betamethasone | None of these genes | Phase 3 |
| Betamethasone Dipropionate | None of these genes | Phase 3 |
| Betamethasone Phosphoric Acid | None of these genes | Phase 3 |
| Busulfan | None of these genes | Phase 3 |
| Cevostamab | None of these genes | Phase 3 |
| Cisplatin | None of these genes | Phase 3 |
| Clarithromycin | None of these genes | Phase 3 |
| Colchicine | None of these genes | Phase 3 |
| Cytarabine | None of these genes | Phase 3 |
| Epoetin Alfa | None of these genes | Phase 3 |
| Epoetin Beta | None of these genes | Phase 3 |
| Equecabtagene Autoleucel | None of these genes | Phase 3 |
| Etentamig | None of these genes | Phase 3 |
| Etoposide | None of these genes | Phase 3 |
| Felzartamab | None of these genes | Phase 3 |
| Filgrastim | None of these genes | Phase 3 |
| Fludarabine | None of these genes | Phase 3 |
| Hyaluronidase | None of these genes | Phase 3 |
| Ibandronic Acid | None of these genes | Phase 3 |
| Iberdomide | None of these genes | Phase 3 |
| Idarubicin | None of these genes | Phase 3 |
| Interferon Alfa | None of these genes | Phase 3 |
| Iron Sucrose | None of these genes | Phase 3 |
| Lenograstim | None of these genes | Phase 3 |
| Lomustine | None of these genes | Phase 3 |
| Masitinib | None of these genes | Phase 3 |
| Methylprednisolone | None of these genes | Phase 3 |
| Methylprednisolone Acetate | None of these genes | Phase 3 |
| Mezigdomide | None of these genes | Phase 3 |
| Molgramostim | None of these genes | Phase 3 |
| Narlumosbart | None of these genes | Phase 3 |
| Nivolumab | None of these genes | Phase 3 |
| Oblimersen | None of these genes | Phase 3 |
| Oblimersen Sodium | None of these genes | Phase 3 |
| Pamidronic Acid | None of these genes | Phase 3 |
| Pegfilgrastim | None of these genes | Phase 3 |
| Peginterferon Alfa-2b | None of these genes | Phase 3 |
| Pembrolizumab | None of these genes | Phase 3 |
| Perifosine | None of these genes | Phase 3 |
| Plitidepsin | None of these genes | Phase 3 |
| Prednisolone | None of these genes | Phase 3 |
| Prednisone | None of these genes | Phase 3 |
| Regramostim | None of these genes | Phase 3 |
| (R)-Melphalan | None of these genes | Phase 3 |
| Sargramostim | None of these genes | Phase 3 |
| Siltuximab | None of these genes | Phase 3 |
| Tabalumab | None of these genes | Phase 3 |
| Tanespimycin | None of these genes | Phase 3 |
| Transplatin | None of these genes | Phase 3 |
| Triamcinolone | None of these genes | Phase 3 |
| Triamcinolone Acetonide | None of these genes | Phase 3 |
| Triamcinolone Hexacetonide | None of these genes | Phase 3 |
| Ulocuplumab | None of these genes | Phase 3 |
| Valspodar | None of these genes | Phase 3 |
| Venetoclax | None of these genes | Phase 3 |
| Vorinostat | None of these genes | Phase 3 |
| 2-Mercaptoethanesulfonic Acid | None of these genes | Phase 2/3 |
| Astuprotimut-R | None of these genes | Phase 2/3 |
| Cetrelimab | None of these genes | Phase 2/3 |
| Interferon | None of these genes | Phase 2/3 |
| Ny-Eso-1 | None of these genes | Phase 2/3 |
| Peginterferon Alfa-2a | None of these genes | Phase 2/3 |
| 2-Methoxyestradiol | None of these genes | Phase 2 |
| 6-O-Benzylguanine | None of these genes | Phase 2 |
| Abatacept | None of these genes | Phase 2 |
| Abemaciclib | None of these genes | Phase 2 |
| Acetylcarnitine | None of these genes | Phase 2 |
| Acyclovir | None of these genes | Phase 2 |
| Adavosertib | None of these genes | Phase 2 |
| Afatinib | None of these genes | Phase 2 |
| Aflibercept | None of these genes | Phase 2 |
| Afuresertib | None of these genes | Phase 2 |
| Aldesleukin | None of these genes | Phase 2 |
| Alectinib | None of these genes | Phase 2 |
| Alemtuzumab | None of these genes | Phase 2 |
| Alpelisib | None of these genes | Phase 2 |
| Alvocidib | None of these genes | Phase 2 |
| Anakinra | None of these genes | Phase 2 |
| Antilymphocyte Immunoglobulin (Horse) | None of these genes | Phase 2 |
| Antineoplaston A10 | None of these genes | Phase 2 |
| Apixaban | None of these genes | Phase 2 |
| Arsenic Trioxide | None of these genes | Phase 2 |
| Ascorbic Acid | None of these genes | Phase 2 |
| Asparaginase | None of these genes | Phase 2 |
| At-9283 | None of these genes | Phase 2 |
| Atezolizumab | None of these genes | Phase 2 |
| Avelumab | None of these genes | Phase 2 |
| Axitinib | None of these genes | Phase 2 |
| Azacitidine | None of these genes | Phase 2 |
| Balixafortide | None of these genes | Phase 2 |
| Belinostat | None of these genes | Phase 2 |
| Bevacizumab | None of these genes | Phase 2 |
| Bhq-880 | None of these genes | Phase 2 |
| Bi-505 | None of these genes | Phase 2 |
| Binimetinib | None of these genes | Phase 2 |
| Biropepimut-S | None of these genes | Phase 2 |
| Bryostatin 1 | None of these genes | Phase 2 |
| Burixafor | None of these genes | Phase 2 |
| Cabozantinib | None of these genes | Phase 2 |
| Canfosfamide | None of these genes | Phase 2 |
| Capivasertib | None of these genes | Phase 2 |
| Carboplatin | None of these genes | Phase 2 |
| Cemiplimab | None of these genes | Phase 2 |
| Cemsidomide | None of these genes | Phase 2 |
| Cetuximab | None of these genes | Phase 2 |
| Chloroquine | None of these genes | Phase 2 |
| Clofarabine | None of these genes | Phase 2 |
| Copanlisib | None of these genes | Phase 2 |
| Crizotinib | None of these genes | Phase 2 |
| Cyclosporine | None of these genes | Phase 2 |
| Dabrafenib | None of these genes | Phase 2 |
| Dacomitinib Anhydrous | None of these genes | Phase 2 |
| Dalteparin Sodium | None of these genes | Phase 2 |
| Danusertib | None of these genes | Phase 2 |
| Darinaparsin | None of these genes | Phase 2 |
| Dasatinib Anhydrous | None of these genes | Phase 2 |
| Defactinib | None of these genes | Phase 2 |
| Delanzomib | None of these genes | Phase 2 |
| Dexamethasone Acetate | None of these genes | Phase 2 |
| Dinaciclib | None of these genes | Phase 2 |
| Dordaviprone | None of these genes | Phase 2 |
| Dostarlimab | None of these genes | Phase 2 |
| Dovitinib | None of these genes | Phase 2 |
| Durvalumab | None of these genes | Phase 2 |
| Eltrombopag | None of these genes | Phase 2 |
| Encorafenib | None of these genes | Phase 2 |
| Entrectinib | None of these genes | Phase 2 |
| Enzastaurin | None of these genes | Phase 2 |
| Erdafitinib | None of these genes | Phase 2 |
| Erlotinib | None of these genes | Phase 2 |
| Etodolac | None of these genes | Phase 2 |
| Everolimus | None of these genes | Phase 2 |
| Fenofibrate | None of these genes | Phase 2 |
| Fexagratinib | None of these genes | Phase 2 |
| Ficlatuzumab | None of these genes | Phase 2 |
| Filanesib | None of these genes | Phase 2 |
| Fluconazole | None of these genes | Phase 2 |
| Fludarabine Phosphate | None of these genes | Phase 2 |
| Galinpepimut-S | None of these genes | Phase 2 |
| Gemcitabine | None of these genes | Phase 2 |
| Givinostat | None of these genes | Phase 2 |
| Glycerol Phenylbutyrate | None of these genes | Phase 2 |
| Gsk-2636771 | None of these genes | Phase 2 |
| Hiltonol | None of these genes | Phase 2 |
| Hydrocortisone | None of these genes | Phase 2 |
| Ibritumomab Tiuxetan | None of these genes | Phase 2 |
| Ibrutinib | None of these genes | Phase 2 |
| Imetelstat | None of these genes | Phase 2 |
| Indatuximab Ravtansine | None of these genes | Phase 2 |
| Inebilizumab | None of these genes | Phase 2 |
| Inobrodib | None of these genes | Phase 2 |
| Interferon Gamma-1b | None of these genes | Phase 2 |
| Interleukin-12 Human Recombinant | None of these genes | Phase 2 |
| Iopofosine | None of these genes | Phase 2 |
| Ipatasertib | None of these genes | Phase 2 |
| Iph-2101 | None of these genes | Phase 2 |
| Ipilimumab | None of these genes | Phase 2 |
| Isotretinoin | None of these genes | Phase 2 |
| Keyhole Limpet Hemocyanin | None of these genes | Phase 2 |
| Larotrectinib | None of these genes | Phase 2 |
| Lcl-161 | None of these genes | Phase 2 |
| Leflunomide | None of these genes | Phase 2 |
| Lenvatinib | None of these genes | Phase 2 |
| Lestaurtinib | None of these genes | Phase 2 |
| Letetresgene Autoleucel | None of these genes | Phase 2 |
| Leucovorin | None of these genes | Phase 2 |
| Leuprolide | None of these genes | Phase 2 |
| Levofloxacin Anhydrous | None of these genes | Phase 2 |
| Lexibulin | None of these genes | Phase 2 |
| Lorlatinib | None of these genes | Phase 2 |
| Luminespib | None of these genes | Phase 2 |
| Magrolimab | None of these genes | Phase 2 |
| Mapatumumab | None of these genes | Phase 2 |
| Maribavir | None of these genes | Phase 2 |
| Marizomib | None of these genes | Phase 2 |
| Mecapegfilgrastim | None of these genes | Phase 2 |
| Meloxicam | None of these genes | Phase 2 |
| Metformin | None of these genes | Phase 2 |
| Methotrexate | None of these genes | Phase 2 |
| Mitoxantrone | None of these genes | Phase 2 |
| Molibresib | None of these genes | Phase 2 |
| Motexafin Gadolinium | None of these genes | Phase 2 |
| Mycophenolate Mofetil | None of these genes | Phase 2 |
| Nelfinavir | None of these genes | Phase 2 |
| Nilotinib | None of these genes | Phase 2 |
| Niraparib | None of these genes | Phase 2 |
| Nirogacestat | None of these genes | Phase 2 |
| Novaferon | None of these genes | Phase 2 |
| Olaparib | None of these genes | Phase 2 |
| Olaptesed Pegol | None of these genes | Phase 2 |
| Osimertinib | None of these genes | Phase 2 |
| Oxygen | None of these genes | Phase 2 |
| Paclitaxel | None of these genes | Phase 2 |
| Palbociclib | None of these genes | Phase 2 |
| Panitumumab | None of these genes | Phase 2 |
| Pasireotide | None of these genes | Phase 2 |
| Pazopanib | None of these genes | Phase 2 |
| Pemigatinib | None of these genes | Phase 2 |
| Pentostatin | None of these genes | Phase 2 |
| Perfosfamide | None of these genes | Phase 2 |
| Pertuzumab | None of these genes | Phase 2 |
| Phenylacetic Acid | None of these genes | Phase 2 |
| Phenylbutanoic Acid | None of these genes | Phase 2 |
| Pidilizumab | None of these genes | Phase 2 |
| Plinabulin | None of these genes | Phase 2 |
| Programmed Cell Death 1 Ligand 1 | None of these genes | Phase 2 |
| Propranolol | None of these genes | Phase 2 |
| Quercetin | None of these genes | Phase 2 |
| Regorafenib | None of these genes | Phase 2 |
| Relatlimab | None of these genes | Phase 2 |
| Rg-4733 | None of these genes | Phase 2 |
| Ribociclib | None of these genes | Phase 2 |
| Rituximab | None of these genes | Phase 2 |
| Romidepsin | None of these genes | Phase 2 |
| Romiplostim | None of these genes | Phase 2 |
| Ropeginterferon Alfa-2b | None of these genes | Phase 2 |
| Rucaparib | None of these genes | Phase 2 |
| Ruxolitinib | None of these genes | Phase 2 |
| Sapanisertib | None of these genes | Phase 2 |
| Selpercatinib | None of these genes | Phase 2 |
| Selumetinib | None of these genes | Phase 2 |
| Semaxanib | None of these genes | Phase 2 |
| Simvastatin | None of these genes | Phase 2 |
| Sonidegib | None of these genes | Phase 2 |
| Sorafenib | None of these genes | Phase 2 |
| Sotatercept | None of these genes | Phase 2 |
| Streptococcus Pneumoniae Polysaccharide Conjugated To Corynebacterium Diphtheriae Crm197 | None of these genes | Phase 2 |
| Sunitinib | None of these genes | Phase 2 |
| Suramin | None of these genes | Phase 2 |
| Tacrolimus Anhydrous | None of these genes | Phase 2 |
| Tadalafil | None of these genes | Phase 2 |
| Talazoparib | None of these genes | Phase 2 |
| Talfirastide | None of these genes | Phase 2 |
| Talmapimod | None of these genes | Phase 2 |
| Taselisib | None of these genes | Phase 2 |
| Tecemotide | None of these genes | Phase 2 |
| Temsirolimus | None of these genes | Phase 2 |
| Tepotinib | None of these genes | Phase 2 |
| Thiotepa | None of these genes | Phase 2 |
| Tipifarnib | None of these genes | Phase 2 |
| Tivantinib | None of these genes | Phase 2 |
| Tocladesine | None of these genes | Phase 2 |
| Topotecan | None of these genes | Phase 2 |
| Tositumomab | None of these genes | Phase 2 |
| Trametinib | None of these genes | Phase 2 |
| Trastuzumab | None of these genes | Phase 2 |
| Trastuzumab Emtansine | None of these genes | Phase 2 |
| Treosulfan | None of these genes | Phase 2 |
| Tretinoin | None of these genes | Phase 2 |
| Troculeucel | None of these genes | Phase 2 |
| Tucidinostat | None of these genes | Phase 2 |
| Ulixertinib | None of these genes | Phase 2 |
| Uprosertib | None of these genes | Phase 2 |
| Vandetanib | None of these genes | Phase 2 |
| Vatalanib | None of these genes | Phase 2 |
| Vemurafenib | None of these genes | Phase 2 |
| Vinorelbine | None of these genes | Phase 2 |
| Vismodegib | None of these genes | Phase 2 |
| Xl-999 | None of these genes | Phase 2 |
| Zinc Sulfate | None of these genes | Phase 2 |
| Abc-294640 | None of these genes | Phase 1/2 |
| Alethine | None of these genes | Phase 1/2 |
| Alisertib | None of these genes | Phase 1/2 |
| Amrubicin | None of these genes | Phase 1/2 |
| Apg-2575 | None of these genes | Phase 1/2 |
| Apricoxib | None of these genes | Phase 1/2 |
| Ar-42 | None of these genes | Phase 1/2 |
| Aspirin | None of these genes | Phase 1/2 |
| At-7519 | None of these genes | Phase 1/2 |
| Atiprimod | None of these genes | Phase 1/2 |
| Belantamab | None of these genes | Phase 1/2 |
| Belumosudil | None of these genes | Phase 1/2 |
| Biw-8962 | None of these genes | Phase 1/2 |
| Brostallicin | None of these genes | Phase 1/2 |
| Cannabidiol | None of these genes | Phase 1/2 |
| Capecitabine | None of these genes | Phase 1/2 |
| Cedazuridine | None of these genes | Phase 1/2 |
| Cerivastatin | None of these genes | Phase 1/2 |
| Cizutamig | None of these genes | Phase 1/2 |
| Cobimetinib | None of these genes | Phase 1/2 |
| Decitabine | None of these genes | Phase 1/2 |
| Defibrotide | None of these genes | Phase 1/2 |
| Dexamethasone Phosphoric Acid | None of these genes | Phase 1/2 |
| Dkn-01 | None of these genes | Phase 1/2 |
| Eltanexor | None of these genes | Phase 1/2 |
| Enasidenib | None of these genes | Phase 1/2 |
| Erzotabart | None of these genes | Phase 1/2 |
| Evofosfamide | None of these genes | Phase 1/2 |
| Evorpacept | None of these genes | Phase 1/2 |
| Ezobresib | None of these genes | Phase 1/2 |
| Feladilimab | None of these genes | Phase 1/2 |
| Fluorouracil | None of these genes | Phase 1/2 |
| Fluphenazine | None of these genes | Phase 1/2 |
| Forimtamig | None of these genes | Phase 1/2 |
| Fosaprepitant | None of these genes | Phase 1/2 |
| Futibatinib | None of these genes | Phase 1/2 |
| Gsk-3174998 | None of these genes | Phase 1/2 |
| Idasanutlin | None of these genes | Phase 1/2 |
| Imexon | None of these genes | Phase 1/2 |
| Irinotecan | None of these genes | Phase 1/2 |
| Kw-2478 | None of these genes | Phase 1/2 |
| Lgh-447 | None of these genes | Phase 1/2 |
| Linperlisib | None of these genes | Phase 1/2 |
| Linsitinib | None of these genes | Phase 1/2 |
| Lipegfilgrastim | None of these genes | Phase 1/2 |
| Lirilumab | None of these genes | Phase 1/2 |
| Lumrotatug | None of these genes | Phase 1/2 |
| Methoxy Polyethylene Glycol-Epoetin Beta | None of these genes | Phase 1/2 |
| Mezagitamab | None of these genes | Phase 1/2 |
| Milatuzumab | None of these genes | Phase 1/2 |
| Mirdametinib | None of these genes | Phase 1/2 |
| Modakafusp Alfa | None of these genes | Phase 1/2 |
| Mp-0250 | None of these genes | Phase 1/2 |
| Muromonab-Cd3 | None of these genes | Phase 1/2 |
| Narazaciclib | None of these genes | Phase 1/2 |
| Natalizumab | None of these genes | Phase 1/2 |
| Nrx195183 | None of these genes | Phase 1/2 |
| Numidargistat | None of these genes | Phase 1/2 |
| Obatoclax | None of these genes | Phase 1/2 |
| Onatasertib | None of these genes | Phase 1/2 |
| Oprozomib | None of these genes | Phase 1/2 |
| Orvacabtagene Autoleucel | None of these genes | Phase 1/2 |
| Osalmid | None of these genes | Phase 1/2 |
| Oxaliplatin | None of these genes | Phase 1/2 |
| P-276-00 | None of these genes | Phase 1/2 |
| Palifermin | None of these genes | Phase 1/2 |
| Pegenzileukin | None of these genes | Phase 1/2 |
| Pelareorep | None of these genes | Phase 1/2 |
| Pemvidutide | None of these genes | Phase 1/2 |
| Pioglitazone | None of these genes | Phase 1/2 |
| Rabacfosadine | None of these genes | Phase 1/2 |
| Radium Ra 223 Dichloride | None of these genes | Phase 1/2 |
| Ricolinostat | None of these genes | Phase 1/2 |
| Rimiducid | None of these genes | Phase 1/2 |
| Samalizumab | None of these genes | Phase 1/2 |
| Samarium Sm 153 Lexidronam Pentasodium | None of these genes | Phase 1/2 |
| Sar-439459 | None of these genes | Phase 1/2 |
| Sonrotoclax | None of these genes | Phase 1/2 |
| Subasumstat | None of these genes | Phase 1/2 |
| Tagraxofusp | None of these genes | Phase 1/2 |
| Tazemetostat | None of these genes | Phase 1/2 |
| Temozolomide | None of these genes | Phase 1/2 |
| Tinostamustine | None of these genes | Phase 1/2 |
| Tiomolibdate Choline | None of these genes | Phase 1/2 |
| Tiragolumab | None of these genes | Phase 1/2 |
| Tosedostat | None of these genes | Phase 1/2 |
| Veliparib | None of these genes | Phase 1/2 |
| Zevorcabtagene Autoleucel | None of these genes | Phase 1/2 |
| Zigakibart | None of these genes | Phase 1/2 |
| Zilurgisertib | None of these genes | Phase 1/2 |
| Abbv-467 | None of these genes | Phase 1 |
| Acalabrutinib | None of these genes | Phase 1 |
| Aew-541 | None of these genes | Phase 1 |
| Aew-541 | None of these genes | Phase 1 |
| Alteminostat | None of these genes | Phase 1 |
| Amg-224 | None of these genes | Phase 1 |
| As-602868 | None of these genes | Phase 1 |
| Atorvastatin | None of these genes | Phase 1 |
| Avadomide | None of these genes | Phase 1 |
| Avutometinib | None of these genes | Phase 1 |
| Azd-5991 | None of these genes | Phase 1 |
| Azintuxizumab Vedotin | None of these genes | Phase 1 |
| Basiliximab | None of these genes | Phase 1 |
| Belrestotug | None of these genes | Phase 1 |
| Bezetabart Debotansine | None of these genes | Phase 1 |
| Birabresib | None of these genes | Phase 1 |
| Bisthianostat | None of these genes | Phase 1 |
| Bms-833923 | None of these genes | Phase 1 |
| Camoteskimab | None of these genes | Phase 1 |
| Catequentinib | None of these genes | Phase 1 |
| Cb-5083 | None of these genes | Phase 1 |
| Cc-115 | None of these genes | Phase 1 |
| Cdx-301 | None of these genes | Phase 1 |
| Celecoxib | None of these genes | Phase 1 |
| Choline Salicylate | None of these genes | Phase 1 |
| Ciforadenant | None of these genes | Phase 1 |
| Citarinostat | None of these genes | Phase 1 |
| Cjm-112 | None of these genes | Phase 1 |
| Copper Gluconate | None of these genes | Phase 1 |
| Crenigacestat | None of these genes | Phase 1 |
| Curcumin | None of these genes | Phase 1 |
| Dacetuzumab | None of these genes | Phase 1 |
| Dalantercept | None of these genes | Phase 1 |
| Dalotuzumab | None of these genes | Phase 1 |
| Disulfiram | None of these genes | Phase 1 |
| D-Mannose | None of these genes | Phase 1 |
| Docetaxel Anhydrous | None of these genes | Phase 1 |
| Eftozanermin Alfa | None of these genes | Phase 1 |
| Enmd-2076 | None of these genes | Phase 1 |
| Enzomenib | None of these genes | Phase 1 |
| Etoposide Phosphate | None of these genes | Phase 1 |
| Ezm-0414 | None of these genes | Phase 1 |
| Fianlimab | None of these genes | Phase 1 |
| Figitumumab | None of these genes | Phase 1 |
| Frenlosirsen | None of these genes | Phase 1 |
| Ganetespib | None of these genes | Phase 1 |
| Go-203-2c | None of these genes | Phase 1 |
| Gossypol Acetic Acid | None of these genes | Phase 1 |
| Gsk2816126 | None of these genes | Phase 1 |
| Human Immunoglobulin G | None of these genes | Phase 1 |
| Hydroxychloroquine | None of these genes | Phase 1 |
| Icovamenib | None of these genes | Phase 1 |
| Imatinib | None of these genes | Phase 1 |
| Imetelstat Sodium | None of these genes | Phase 1 |
| Imifoplatin | None of these genes | Phase 1 |
| Inbakicept | None of these genes | Phase 1 |
| Incomplete Freund'S Adjuvant | None of these genes | Phase 1 |
| Ingitamig | None of these genes | Phase 1 |
| Interleukin-7 | None of these genes | Phase 1 |
| Itraconazole | None of these genes | Phase 1 |
| Lapachone | None of these genes | Phase 1 |
| Lapatinib | None of these genes | Phase 1 |
| Lemzoparlimab | None of these genes | Phase 1 |
| Lintuzumab | None of these genes | Phase 1 |
| Lorvotuzumab Mertansine | None of these genes | Phase 1 |
| Lucatumumab | None of these genes | Phase 1 |
| Maplirpacept | None of these genes | Phase 1 |
| Medi-7247 | None of these genes | Phase 1 |
| Methylpyrrolidone | None of these genes | Phase 1 |
| Mik-665 | None of these genes | Phase 1 |
| Milademetan | None of these genes | Phase 1 |
| Mivebresib | None of these genes | Phase 1 |
| Napabucasin | None of these genes | Phase 1 |
| Navtemadlin | None of these genes | Phase 1 |
| Nendocabtagene Onogedleucel | None of these genes | Phase 1 |
| Nintedanib | None of these genes | Phase 1 |
| Nogapendekin Alfa | None of these genes | Phase 1 |
| Noraramtide | None of these genes | Phase 1 |
| Noscapine | None of these genes | Phase 1 |
| Pacanalotamab | None of these genes | Phase 1 |
| Paricalcitol | None of these genes | Phase 1 |
| Pavurutamab | None of these genes | Phase 1 |
| Pelabresib | None of these genes | Phase 1 |
| Pevonedistat | None of these genes | Phase 1 |
| Pf-06688992 | None of these genes | Phase 1 |
| Podentamig | None of these genes | Phase 1 |
| Pralatrexate | None of these genes | Phase 1 |
| Quisinostat | None of these genes | Phase 1 |
| Retaspimycin | None of these genes | Phase 1 |
| Rg-7598 | None of these genes | Phase 1 |
| Ridaforolimus | None of these genes | Phase 1 |
| Rigosertib | None of these genes | Phase 1 |
| Ritonavir | None of these genes | Phase 1 |
| Ro-6870810 | None of these genes | Phase 1 |
| Roneparstat | None of these genes | Phase 1 |
| Sea-Bcma | None of these genes | Phase 1 |
| Selvigaltin | None of these genes | Phase 1 |
| Sgn-Cd352a | None of these genes | Phase 1 |
| Silmitasertib | None of these genes | Phase 1 |
| Sodium Iodide | None of these genes | Phase 1 |
| Sodium Stibogluconate | None of these genes | Phase 1 |
| Spartalizumab | None of these genes | Phase 1 |
| Svn53-67/M57-Klh Peptide Vaccine | None of these genes | Phase 1 |
| Sx-682 | None of these genes | Phase 1 |
| Taniraleucel | None of these genes | Phase 1 |
| Tapotoclax | None of these genes | Phase 1 |
| Tasquinimod | None of these genes | Phase 1 |
| Teglarinad | None of these genes | Phase 1 |
| Telaglenastat | None of these genes | Phase 1 |
| Thiourea, N-(5-Bromo-2-Pyridinyl)-N'-(2-(2-Chloro-3-Ethoxy-6-Fluorophenyl)Ethyl)- | None of these genes | Phase 1 |
| Timdarpacept | None of these genes | Phase 1 |
| Tisagenlecleucel | None of these genes | Phase 1 |
| Tocilizumab | None of these genes | Phase 1 |
| Tremelimumab | None of these genes | Phase 1 |
| Uproleselan | None of these genes | Phase 1 |
| Urelumab | None of these genes | Phase 1 |
| Vactosertib | None of these genes | Phase 1 |
| Veligrotug | None of these genes | Phase 1 |
| Vevoctadekin | None of these genes | Phase 1 |
| Vob-560 | None of these genes | Phase 1 |
| Vofatamab | None of these genes | Phase 1 |
| Zabadinostat | None of these genes | Phase 1 |
| Zotiraciclib | None of these genes | Phase 1 |
| Blinatumomab | None of these genes | Early phase 1 |
| Cholecalciferol | None of these genes | Early phase 1 |
| Interleukin 6 | None of these genes | Early phase 1 |
| Roflumilast | None of these genes | Early phase 1 |
| Dacinostat | None of these genes | Investigational new drug |
| Telomestatin | None of these genes | Investigational new drug |
| Tmpyp4 | None of these genes | Investigational new drug |
| Trapidil | None of these genes | Investigational new drug |
| Tubacin | None of these genes | Investigational new drug |
| Alendronic Acid | None of these genes | Unknown |
| Desipramine | None of these genes | Unknown |
| Lalikinogene Sifuplasmid | None of these genes | Unknown |
| Lisocabtagene Maraleucel | None of these genes | Unknown |
| Piperine | None of these genes | Unknown |
| Recombinant Human Thrombopoietin | None of these genes | Unknown |
| Tamoxifen | None of these genes | Unknown |
| Voriconazole | None of these genes | Unknown |
| Zoxazolamine | None of these genes | Unknown |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.